Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Elashoff

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Annual Review of Biophysics and Bioengineering|January 1, 1976
Two stage screening designs applied to chemical-screening problems with binary dataR M Elashoff
Statistics in Medicine|November 15, 1996
HIV treatment strategies utilizing virologic and immunologic markers as criteria for changing treatmentsM Elashoff, S Lagakos
Transactions of the New York Academy of Sciences|November 1, 1972
Mortality in syngeneic rat parabionts of different chronological ageF C Ludwig, R M Elashoff
Lifetime Data Analysis|January 1, 1996
A three-state disease model with interval-censored data: estimation and applications to AIDS and cancerK M Leung, R M Elashoff
Statistics in Medicine|June 30, 1994
Analysis of longitudinal data: random coefficient regression modellingC M Rutter, R M Elashoff
Statistics in Medicine|January 1, 1987
Effect of covariate measurement error in randomized clinical trialsT M Morgan, R M Elashoff
Biometrics|December 29, 2007
A joint model for longitudinal measurements and survival data in the presence of multiple failure typesRobert M Elashoff, Gang Li, Ning Li
Biometrika|July 12, 2013
Nonparametric inference for assessing treatment efficacy in randomized clinical trials with a time-to-event outcome and all-or-none complianceRobert M Elashoff, Gang Li, Ying Zhou
The Lancet. Neurology|June 16, 2016
Why use sex hormones in relapsing-remitting multiple sclerosis? - Authors' replyRhonda Voskuhl, HeJing Wang, Robert M Elashoff
Statistics and Its Interface|September 6, 2011
A joint model of longitudinal and competing risks survival data with heterogeneous random effects and outlying longitudinal measurementsXin Huang, Gang Li, Robert M Elashoff
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Annual Review of Biophysics and Bioengineering|January 1, 1976
Two stage screening designs applied to chemical-screening problems with binary dataR M Elashoff
Statistics in Medicine|November 15, 1996
HIV treatment strategies utilizing virologic and immunologic markers as criteria for changing treatmentsM Elashoff, S Lagakos
Transactions of the New York Academy of Sciences|November 1, 1972
Mortality in syngeneic rat parabionts of different chronological ageF C Ludwig, R M Elashoff
Lifetime Data Analysis|January 1, 1996
A three-state disease model with interval-censored data: estimation and applications to AIDS and cancerK M Leung, R M Elashoff
Statistics in Medicine|June 30, 1994
Analysis of longitudinal data: random coefficient regression modellingC M Rutter, R M Elashoff
Statistics in Medicine|January 1, 1987
Effect of covariate measurement error in randomized clinical trialsT M Morgan, R M Elashoff
Biometrics|December 29, 2007
A joint model for longitudinal measurements and survival data in the presence of multiple failure typesRobert M Elashoff, Gang Li, Ning Li
Biometrika|July 12, 2013
Nonparametric inference for assessing treatment efficacy in randomized clinical trials with a time-to-event outcome and all-or-none complianceRobert M Elashoff, Gang Li, Ying Zhou
The Lancet. Neurology|June 16, 2016
Why use sex hormones in relapsing-remitting multiple sclerosis? - Authors' replyRhonda Voskuhl, HeJing Wang, Robert M Elashoff
Statistics and Its Interface|September 6, 2011
A joint model of longitudinal and competing risks survival data with heterogeneous random effects and outlying longitudinal measurementsXin Huang, Gang Li, Robert M Elashoff
Pageof 15